Effects of Rimonabant on Metabolic Risk Factors in Overweight Patients With Dyslipidemia

@inproceedings{Bessesen2006EffectsOR,
  title={Effects of Rimonabant on Metabolic Risk Factors in Overweight Patients With Dyslipidemia},
  author={Daniel H. Bessesen},
  year={2006}
}

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 456 CITATIONS

Adipokines--targeting a root cause of cardiometabolic risk.

  • QJM : monthly journal of the Association of Physicians
  • 2008
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Endocannabinoids and obesity.

  • Vitamins and hormones
  • 2013
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Prävention kardiovaskulärer Erkrankungen durch Blockade des Endocannabinoidsystems

  • Herz Kardiovaskuläre Erkrankungen
  • 2007
VIEW 11 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2004
2018

CITATION STATISTICS

  • 14 Highly Influenced Citations

  • Averaged 16 Citations per year over the last 3 years

Similar Papers

Loading similar papers…